FTC: end drug patent settlements to save $35B
Posted by Mary Canady on June 23 2009
No Comments
The chairman of the Federal Trade Commission says eliminating lucrative patent settlements between brand-name and generic drug companies would save consumers $3.5 billion annually.
See other entries categorized in News, San Diego Union Tribune, Syndication.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
